SlideShare a Scribd company logo
1 of 3
GEETHANJALI COLLEGE OF PHARMACY
IMPORTANT QUESTIONS
3RD YEAR 2ND SEM BIOPHARMACEUTICS AND PHARMACOKINETICS
UNIT: I
1. Compare and contrast passive diffusion and carrier mediated transport.
2. How the drugs are transported across BBB.
3. What is product inhibition give examples of drugs show this?
4. List the different biological factors influence the absorption of drugs.
5. Explain formulation factors influence the absorption of drugs.
6. Explain pH- partition hypothesis.
7. Micronization of drugs leads to decrease in drug absorption, Justify.
8. Enumerate the differences between passive and active transport mechanisms with their relative
advantages and disadvantages and suitable examples.
9. What is prodrug? Discuss the effect of enzyme inducer and inhibitors on drug biotransformation.
10. Give Noyes-Whitney equation and mention the role of each parameter in the equation.
11. What are the two rate-limiting steps in the oral absorption of a solid drug product? Discuss the effect
of disintegrants and binders on the absorption of drugs from GIT.
UNIT: II
1. What is i) Chemical and pharmaceutical equivalence ii) Therapeutic and Bioequivalence.
2. Why drug protein binding will effect only glomerular filtration compared to tubular secretion?
3. Discuss the effect of alkalization or acidification of the urine on the renal clearance of weak
base with a pKa of 9.6.
4. Discuss the a) Process of renal elimination b) Factors influencing passive reabsorption of drug from
tubules
5. Interpret the bioavailability studies for approved drugs.
6. Write the factors of drug distribution and write briefly on volume of distribution.
7. Describe different properties of drugs that influence its distribution.
8. Discuss the role of protein binding on distribution and effect of drugs.
9. Construct the study design for bio equivalent studies.
10. Discuss the procedure and protocol (CDSCO) for testing of bioavailability of drugs.
11. Discuss the binding of drugs to various proteins by giving examples.
12. Write about the kinetics of protein binding.
13. Describe the concept of drug clearance by glomerular filtration and tubular secretion.
14. Write about the significance of drug excretion.
15. What is the role of glomerular filtration in drug excretion and write methods used to determine GFR?
16. Write about excretion of drug through i) bile ii) lungs
17. Define therapeutic equivalent, therapeutic substitution, Brand drug and generic drug.
18. Write oxidative-reductive pathway of drug metabolism. Write few examples in this section.
19. What is ANOVA? How it is determined? What are the parameters required? How significance and not
significance can be determined.
20. What are the different t-tests applied and write its differences? Give the steps involved in unpaired t-
test?
21. Write a note on: i) Histogram ii) Regression equations.
22. Enumerate different biostatistical methods and explain t-test and regression analysis.
23. Write short note on the following: a) Hydrolytic reactions b) Kinetics of protein binding c) In vitro-in
vivo correlation
24. Write different in-vitro dissolution studies for solid dosage forms. Explain about pH- partition
Hypothesis in detail.
25. Explain about the principal processes of drug excretion through the kidneys. Explain about effect of
urine pH on drug excretion through kidneys.
26. Explain about curve fitting and regression analysis. Write about t- test.
27. Discuss that bioavailability testing procedure and protocol as per CDSCO.
UNIT: III
1. Compare and contrast Pharmacokinetics and Pharmacodynamics.
2. Choose the formula to calculate Vd and define it.
3. Describe the theory of probability and its significance in pharmacokinetics
4. What is Km and Vmax.
5. Find a method for estimation of Vmax.
6. Discuss Biopharmaceutical Classification System by giving examples.
7. Classify compartment modeling. Merits and demerits?
8. Draw a typical plasma drug concentration curve and explain its salient features.
9. Explain about the methods of residuals used for the determination of absorption rate constant.
10. Write the determination of one compartment open IV bolus equation. Draw plasma concentration time
curve and explain each parameter after oral administration of drug.
11. Write the significance of compartment modeling? Write the calculation of pharmacokinetic
parameters from urinary data?
12. Write the determination of absorption rate constant by different methods.
13. Define one-compartment open model. Derive the equations to calculate plasma concentration of drug
for I.V.Bolus. Define Biological half life of a drug and it’s importance.
14. Define the following:
15. i) Biopharmaceutics ii) Pharmacokinetics
iii) Pharmacodynamics iv) Therapeutic index
UNIT: IV
No significant questions found and given previously from two compartment model
UNIT: V
1. Illustrate the Methylation reaction for metabolism of drugs.
2. Explain Phase II metabolism by giving examples.
3. Discuss: a) Glucuronic acid conjugation b) Glutathione conjugation of drugs.
4. Compile enzyme induction and inhibitions.
5. Write the reasons for drugs exhibiting nonlinear pharmacokinetics.
6. Describe about oxidative biotransformation of drugs with examples.
7. Write overview on non linear pharmacokinetics.
8. Enumerate different Phase-II metabolic reactions and explain any two of them. Write about Enzyme
induction.
9. Discuss in detail different oxidative reactions with suitable examples.
10. What is non-linear pharmacokinetics and discuss the reasons behind non-linearity and how it effects
the clinical output of any drug?

More Related Content

What's hot

Pediatrics, Geriatrics, Pregnancy, Lactation
Pediatrics, Geriatrics, Pregnancy, LactationPediatrics, Geriatrics, Pregnancy, Lactation
Pediatrics, Geriatrics, Pregnancy, LactationBikashAdhikari26
 
Certificate of pharmaceutical product
Certificate of pharmaceutical productCertificate of pharmaceutical product
Certificate of pharmaceutical productAtul Bhombe
 
Misbranded and spurious cosmetics
Misbranded and spurious cosmeticsMisbranded and spurious cosmetics
Misbranded and spurious cosmeticsForam Machhar
 
Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]Sagar Savale
 
Presentation on transdermal drug delivery system
Presentation on transdermal drug delivery systemPresentation on transdermal drug delivery system
Presentation on transdermal drug delivery systemShresthaPandey1
 
Patients medication history interview
Patients medication history interviewPatients medication history interview
Patients medication history interviewSubhash Yende
 
Optimization techniques in pharmaceutical formulation and processing
Optimization techniques in pharmaceutical formulation and processingOptimization techniques in pharmaceutical formulation and processing
Optimization techniques in pharmaceutical formulation and processingPratiksha Chandragirivar
 
PHARMACEUTICAL PRODUCT DEVELOPMENT
PHARMACEUTICAL PRODUCT DEVELOPMENTPHARMACEUTICAL PRODUCT DEVELOPMENT
PHARMACEUTICAL PRODUCT DEVELOPMENTDeepthiKolluru1
 
FDA Data Standards An Update
FDA Data Standards An UpdateFDA Data Standards An Update
FDA Data Standards An Updateshakulbio
 
Formulation and evaluation of tdds
Formulation and evaluation of tddsFormulation and evaluation of tdds
Formulation and evaluation of tddsPankaj Verma
 
Bcs classification by sneha gaurkar
Bcs classification by sneha gaurkarBcs classification by sneha gaurkar
Bcs classification by sneha gaurkarSneha Gaurkar
 
Investigational use of drugs
Investigational use of drugsInvestigational use of drugs
Investigational use of drugssunayanamali
 
Biopharmaceutics classification system
Biopharmaceutics classification systemBiopharmaceutics classification system
Biopharmaceutics classification systemAshwani Kumar Singh
 
Drug Price Control Order -2013
Drug Price Control Order -2013Drug Price Control Order -2013
Drug Price Control Order -2013Ganesh Shevalkar
 
Implantable Drug Delivery System
Implantable Drug Delivery SystemImplantable Drug Delivery System
Implantable Drug Delivery SystemSourav Kar
 
Mucosal Drug Delivery System
Mucosal Drug Delivery SystemMucosal Drug Delivery System
Mucosal Drug Delivery SystemSwatiSen3
 
Gastrointestinal absorption of drugs
Gastrointestinal absorption of drugsGastrointestinal absorption of drugs
Gastrointestinal absorption of drugsSiddu K M
 

What's hot (20)

Pediatrics, Geriatrics, Pregnancy, Lactation
Pediatrics, Geriatrics, Pregnancy, LactationPediatrics, Geriatrics, Pregnancy, Lactation
Pediatrics, Geriatrics, Pregnancy, Lactation
 
Certificate of pharmaceutical product
Certificate of pharmaceutical productCertificate of pharmaceutical product
Certificate of pharmaceutical product
 
Misbranded and spurious cosmetics
Misbranded and spurious cosmeticsMisbranded and spurious cosmetics
Misbranded and spurious cosmetics
 
Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]Bio pharmaceutical classification System [BCS]
Bio pharmaceutical classification System [BCS]
 
Presentation on transdermal drug delivery system
Presentation on transdermal drug delivery systemPresentation on transdermal drug delivery system
Presentation on transdermal drug delivery system
 
Patients medication history interview
Patients medication history interviewPatients medication history interview
Patients medication history interview
 
Optimization techniques in pharmaceutical formulation and processing
Optimization techniques in pharmaceutical formulation and processingOptimization techniques in pharmaceutical formulation and processing
Optimization techniques in pharmaceutical formulation and processing
 
PHARMACEUTICAL PRODUCT DEVELOPMENT
PHARMACEUTICAL PRODUCT DEVELOPMENTPHARMACEUTICAL PRODUCT DEVELOPMENT
PHARMACEUTICAL PRODUCT DEVELOPMENT
 
Nasopulmonary Drug Delivery System
Nasopulmonary Drug Delivery SystemNasopulmonary Drug Delivery System
Nasopulmonary Drug Delivery System
 
FDA Data Standards An Update
FDA Data Standards An UpdateFDA Data Standards An Update
FDA Data Standards An Update
 
Formulation and evaluation of tdds
Formulation and evaluation of tddsFormulation and evaluation of tdds
Formulation and evaluation of tdds
 
Clinical Pharmacy
Clinical PharmacyClinical Pharmacy
Clinical Pharmacy
 
Bcs classification by sneha gaurkar
Bcs classification by sneha gaurkarBcs classification by sneha gaurkar
Bcs classification by sneha gaurkar
 
Supac
SupacSupac
Supac
 
Investigational use of drugs
Investigational use of drugsInvestigational use of drugs
Investigational use of drugs
 
Biopharmaceutics classification system
Biopharmaceutics classification systemBiopharmaceutics classification system
Biopharmaceutics classification system
 
Drug Price Control Order -2013
Drug Price Control Order -2013Drug Price Control Order -2013
Drug Price Control Order -2013
 
Implantable Drug Delivery System
Implantable Drug Delivery SystemImplantable Drug Delivery System
Implantable Drug Delivery System
 
Mucosal Drug Delivery System
Mucosal Drug Delivery SystemMucosal Drug Delivery System
Mucosal Drug Delivery System
 
Gastrointestinal absorption of drugs
Gastrointestinal absorption of drugsGastrointestinal absorption of drugs
Gastrointestinal absorption of drugs
 

Similar to Important Questions BPPK 3rd year 2nd Sem.docx

Clinical Pharmacokinetics &Pharmacotherapeutic Drug Monitoring 5th Pharm D.pdf
Clinical Pharmacokinetics &Pharmacotherapeutic Drug Monitoring 5th Pharm D.pdfClinical Pharmacokinetics &Pharmacotherapeutic Drug Monitoring 5th Pharm D.pdf
Clinical Pharmacokinetics &Pharmacotherapeutic Drug Monitoring 5th Pharm D.pdfAnkurDas79
 
B. pharm. course outcomes According to PCI syllabus fir NBA
B. pharm. course outcomes According to PCI syllabus fir NBAB. pharm. course outcomes According to PCI syllabus fir NBA
B. pharm. course outcomes According to PCI syllabus fir NBASnehalChakorkar
 
B. pharm. course outcomes Even semester dr. amit gangwal & ms. s. s. chakorkar
B. pharm. course outcomes Even semester dr. amit gangwal & ms. s. s. chakorkarB. pharm. course outcomes Even semester dr. amit gangwal & ms. s. s. chakorkar
B. pharm. course outcomes Even semester dr. amit gangwal & ms. s. s. chakorkarSnehalChakorkar
 
6th Sem BPharm.pdf
6th Sem BPharm.pdf6th Sem BPharm.pdf
6th Sem BPharm.pdfSomSingh23
 
12.09.2022-BP-PCI-SEM-612July2022.pdf
12.09.2022-BP-PCI-SEM-612July2022.pdf12.09.2022-BP-PCI-SEM-612July2022.pdf
12.09.2022-BP-PCI-SEM-612July2022.pdfAnarulIslam17
 
Invitro invivo correlation
Invitro invivo correlationInvitro invivo correlation
Invitro invivo correlationNagaraju Ravouru
 
Metabolite Likeness for selection of pharmaceutical drug libraries
Metabolite Likeness for selection of pharmaceutical drug librariesMetabolite Likeness for selection of pharmaceutical drug libraries
Metabolite Likeness for selection of pharmaceutical drug librariesAnkit Dhaundiyal
 
Regulatory Considerations for Excipients used in Lipid Nanoparticles
Regulatory Considerations for Excipients used in Lipid NanoparticlesRegulatory Considerations for Excipients used in Lipid Nanoparticles
Regulatory Considerations for Excipients used in Lipid NanoparticlesMerck Life Sciences
 
B. pharm. i vth year syllabus (3)
B. pharm. i vth year syllabus (3)B. pharm. i vth year syllabus (3)
B. pharm. i vth year syllabus (3)lalit mathuriya
 
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptxPREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptxMO.SHAHANAWAZ
 
Clinical Pharmacy.pptx
Clinical Pharmacy.pptxClinical Pharmacy.pptx
Clinical Pharmacy.pptxVijay Meti
 
Bioanalysis significance 12 oct 2022.ppt
Bioanalysis significance 12 oct 2022.pptBioanalysis significance 12 oct 2022.ppt
Bioanalysis significance 12 oct 2022.pptDr. Manoj Kumbhare
 
Computational modelling of drug disposition
Computational modelling of drug disposition Computational modelling of drug disposition
Computational modelling of drug disposition lalitajoshi9
 
Bioavailability study
Bioavailability studyBioavailability study
Bioavailability studyYogesh Tiwari
 
INTRODUCTION TO BIOPHARMACEUTICS & ABSORPTION
INTRODUCTION TO BIOPHARMACEUTICS & ABSORPTION INTRODUCTION TO BIOPHARMACEUTICS & ABSORPTION
INTRODUCTION TO BIOPHARMACEUTICS & ABSORPTION Ram Kanth
 
Computer- aided biopharmaceutical characterization.pptx
Computer- aided biopharmaceutical characterization.pptxComputer- aided biopharmaceutical characterization.pptx
Computer- aided biopharmaceutical characterization.pptxSumant Saini
 
Review on Pharmacivigilance and mucomycocis disease
Review on Pharmacivigilance and  mucomycocis disease Review on Pharmacivigilance and  mucomycocis disease
Review on Pharmacivigilance and mucomycocis disease VaishnaviMore55
 
Med chem by the numbers
Med chem by the numbersMed chem by the numbers
Med chem by the numbersGraham Smith
 

Similar to Important Questions BPPK 3rd year 2nd Sem.docx (20)

Clinical Pharmacokinetics &Pharmacotherapeutic Drug Monitoring 5th Pharm D.pdf
Clinical Pharmacokinetics &Pharmacotherapeutic Drug Monitoring 5th Pharm D.pdfClinical Pharmacokinetics &Pharmacotherapeutic Drug Monitoring 5th Pharm D.pdf
Clinical Pharmacokinetics &Pharmacotherapeutic Drug Monitoring 5th Pharm D.pdf
 
B. Pharm. course outcomes as per NBA
B. Pharm. course outcomes as per NBAB. Pharm. course outcomes as per NBA
B. Pharm. course outcomes as per NBA
 
B. pharm. course outcomes According to PCI syllabus fir NBA
B. pharm. course outcomes According to PCI syllabus fir NBAB. pharm. course outcomes According to PCI syllabus fir NBA
B. pharm. course outcomes According to PCI syllabus fir NBA
 
B. pharm. course outcomes Even semester dr. amit gangwal & ms. s. s. chakorkar
B. pharm. course outcomes Even semester dr. amit gangwal & ms. s. s. chakorkarB. pharm. course outcomes Even semester dr. amit gangwal & ms. s. s. chakorkar
B. pharm. course outcomes Even semester dr. amit gangwal & ms. s. s. chakorkar
 
6th Sem BPharm.pdf
6th Sem BPharm.pdf6th Sem BPharm.pdf
6th Sem BPharm.pdf
 
12.09.2022-BP-PCI-SEM-612July2022.pdf
12.09.2022-BP-PCI-SEM-612July2022.pdf12.09.2022-BP-PCI-SEM-612July2022.pdf
12.09.2022-BP-PCI-SEM-612July2022.pdf
 
Invitro invivo correlation
Invitro invivo correlationInvitro invivo correlation
Invitro invivo correlation
 
Metabolite Likeness for selection of pharmaceutical drug libraries
Metabolite Likeness for selection of pharmaceutical drug librariesMetabolite Likeness for selection of pharmaceutical drug libraries
Metabolite Likeness for selection of pharmaceutical drug libraries
 
Regulatory Considerations for Excipients used in Lipid Nanoparticles
Regulatory Considerations for Excipients used in Lipid NanoparticlesRegulatory Considerations for Excipients used in Lipid Nanoparticles
Regulatory Considerations for Excipients used in Lipid Nanoparticles
 
B. pharm. i vth year syllabus (3)
B. pharm. i vth year syllabus (3)B. pharm. i vth year syllabus (3)
B. pharm. i vth year syllabus (3)
 
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptxPREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
 
Clinical Pharmacy.pptx
Clinical Pharmacy.pptxClinical Pharmacy.pptx
Clinical Pharmacy.pptx
 
Bioanalysis significance 12 oct 2022.ppt
Bioanalysis significance 12 oct 2022.pptBioanalysis significance 12 oct 2022.ppt
Bioanalysis significance 12 oct 2022.ppt
 
Pmy 3020 course handbook 2014
Pmy 3020 course handbook 2014Pmy 3020 course handbook 2014
Pmy 3020 course handbook 2014
 
Computational modelling of drug disposition
Computational modelling of drug disposition Computational modelling of drug disposition
Computational modelling of drug disposition
 
Bioavailability study
Bioavailability studyBioavailability study
Bioavailability study
 
INTRODUCTION TO BIOPHARMACEUTICS & ABSORPTION
INTRODUCTION TO BIOPHARMACEUTICS & ABSORPTION INTRODUCTION TO BIOPHARMACEUTICS & ABSORPTION
INTRODUCTION TO BIOPHARMACEUTICS & ABSORPTION
 
Computer- aided biopharmaceutical characterization.pptx
Computer- aided biopharmaceutical characterization.pptxComputer- aided biopharmaceutical characterization.pptx
Computer- aided biopharmaceutical characterization.pptx
 
Review on Pharmacivigilance and mucomycocis disease
Review on Pharmacivigilance and  mucomycocis disease Review on Pharmacivigilance and  mucomycocis disease
Review on Pharmacivigilance and mucomycocis disease
 
Med chem by the numbers
Med chem by the numbersMed chem by the numbers
Med chem by the numbers
 

Recently uploaded

FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and SpectrometryFAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and SpectrometryAlex Henderson
 
FAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceFAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceAlex Henderson
 
Pteris : features, anatomy, morphology and lifecycle
Pteris : features, anatomy, morphology and lifecyclePteris : features, anatomy, morphology and lifecycle
Pteris : features, anatomy, morphology and lifecycleCherry
 
GBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolationGBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolationAreesha Ahmad
 
Efficient spin-up of Earth System Models usingsequence acceleration
Efficient spin-up of Earth System Models usingsequence accelerationEfficient spin-up of Earth System Models usingsequence acceleration
Efficient spin-up of Earth System Models usingsequence accelerationSérgio Sacani
 
Concept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdfConcept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdfCherry
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...Scintica Instrumentation
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Cherry
 
Dr. E. Muralinath_ Blood indices_clinical aspects
Dr. E. Muralinath_ Blood indices_clinical  aspectsDr. E. Muralinath_ Blood indices_clinical  aspects
Dr. E. Muralinath_ Blood indices_clinical aspectsmuralinath2
 
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry Areesha Ahmad
 
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptxClimate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptxDiariAli
 
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....muralinath2
 
GBSN - Biochemistry (Unit 3) Metabolism
GBSN - Biochemistry (Unit 3) MetabolismGBSN - Biochemistry (Unit 3) Metabolism
GBSN - Biochemistry (Unit 3) MetabolismAreesha Ahmad
 
Understanding Partial Differential Equations: Types and Solution Methods
Understanding Partial Differential Equations: Types and Solution MethodsUnderstanding Partial Differential Equations: Types and Solution Methods
Understanding Partial Differential Equations: Types and Solution Methodsimroshankoirala
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptxCherry
 
X-rays from a Central “Exhaust Vent” of the Galactic Center Chimney
X-rays from a Central “Exhaust Vent” of the Galactic Center ChimneyX-rays from a Central “Exhaust Vent” of the Galactic Center Chimney
X-rays from a Central “Exhaust Vent” of the Galactic Center ChimneySérgio Sacani
 
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.Cherry
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusNazaninKarimi6
 
Role of AI in seed science Predictive modelling and Beyond.pptx
Role of AI in seed science  Predictive modelling and  Beyond.pptxRole of AI in seed science  Predictive modelling and  Beyond.pptx
Role of AI in seed science Predictive modelling and Beyond.pptxArvind Kumar
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxRenuJangid3
 

Recently uploaded (20)

FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and SpectrometryFAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
FAIRSpectra - Enabling the FAIRification of Spectroscopy and Spectrometry
 
FAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical ScienceFAIRSpectra - Enabling the FAIRification of Analytical Science
FAIRSpectra - Enabling the FAIRification of Analytical Science
 
Pteris : features, anatomy, morphology and lifecycle
Pteris : features, anatomy, morphology and lifecyclePteris : features, anatomy, morphology and lifecycle
Pteris : features, anatomy, morphology and lifecycle
 
GBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolationGBSN - Microbiology (Unit 5) Concept of isolation
GBSN - Microbiology (Unit 5) Concept of isolation
 
Efficient spin-up of Earth System Models usingsequence acceleration
Efficient spin-up of Earth System Models usingsequence accelerationEfficient spin-up of Earth System Models usingsequence acceleration
Efficient spin-up of Earth System Models usingsequence acceleration
 
Concept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdfConcept of gene and Complementation test.pdf
Concept of gene and Complementation test.pdf
 
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
(May 9, 2024) Enhanced Ultrafast Vector Flow Imaging (VFI) Using Multi-Angle ...
 
Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.Reboulia: features, anatomy, morphology etc.
Reboulia: features, anatomy, morphology etc.
 
Dr. E. Muralinath_ Blood indices_clinical aspects
Dr. E. Muralinath_ Blood indices_clinical  aspectsDr. E. Muralinath_ Blood indices_clinical  aspects
Dr. E. Muralinath_ Blood indices_clinical aspects
 
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry
GBSN - Biochemistry (Unit 2) Basic concept of organic chemistry
 
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptxClimate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
Climate Change Impacts on Terrestrial and Aquatic Ecosystems.pptx
 
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
Human & Veterinary Respiratory Physilogy_DR.E.Muralinath_Associate Professor....
 
GBSN - Biochemistry (Unit 3) Metabolism
GBSN - Biochemistry (Unit 3) MetabolismGBSN - Biochemistry (Unit 3) Metabolism
GBSN - Biochemistry (Unit 3) Metabolism
 
Understanding Partial Differential Equations: Types and Solution Methods
Understanding Partial Differential Equations: Types and Solution MethodsUnderstanding Partial Differential Equations: Types and Solution Methods
Understanding Partial Differential Equations: Types and Solution Methods
 
Human genetics..........................pptx
Human genetics..........................pptxHuman genetics..........................pptx
Human genetics..........................pptx
 
X-rays from a Central “Exhaust Vent” of the Galactic Center Chimney
X-rays from a Central “Exhaust Vent” of the Galactic Center ChimneyX-rays from a Central “Exhaust Vent” of the Galactic Center Chimney
X-rays from a Central “Exhaust Vent” of the Galactic Center Chimney
 
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.Cyathodium bryophyte: morphology, anatomy, reproduction etc.
Cyathodium bryophyte: morphology, anatomy, reproduction etc.
 
development of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virusdevelopment of diagnostic enzyme assay to detect leuser virus
development of diagnostic enzyme assay to detect leuser virus
 
Role of AI in seed science Predictive modelling and Beyond.pptx
Role of AI in seed science  Predictive modelling and  Beyond.pptxRole of AI in seed science  Predictive modelling and  Beyond.pptx
Role of AI in seed science Predictive modelling and Beyond.pptx
 
Use of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptxUse of mutants in understanding seedling development.pptx
Use of mutants in understanding seedling development.pptx
 

Important Questions BPPK 3rd year 2nd Sem.docx

  • 1. GEETHANJALI COLLEGE OF PHARMACY IMPORTANT QUESTIONS 3RD YEAR 2ND SEM BIOPHARMACEUTICS AND PHARMACOKINETICS UNIT: I 1. Compare and contrast passive diffusion and carrier mediated transport. 2. How the drugs are transported across BBB. 3. What is product inhibition give examples of drugs show this? 4. List the different biological factors influence the absorption of drugs. 5. Explain formulation factors influence the absorption of drugs. 6. Explain pH- partition hypothesis. 7. Micronization of drugs leads to decrease in drug absorption, Justify. 8. Enumerate the differences between passive and active transport mechanisms with their relative advantages and disadvantages and suitable examples. 9. What is prodrug? Discuss the effect of enzyme inducer and inhibitors on drug biotransformation. 10. Give Noyes-Whitney equation and mention the role of each parameter in the equation. 11. What are the two rate-limiting steps in the oral absorption of a solid drug product? Discuss the effect of disintegrants and binders on the absorption of drugs from GIT. UNIT: II 1. What is i) Chemical and pharmaceutical equivalence ii) Therapeutic and Bioequivalence. 2. Why drug protein binding will effect only glomerular filtration compared to tubular secretion? 3. Discuss the effect of alkalization or acidification of the urine on the renal clearance of weak base with a pKa of 9.6. 4. Discuss the a) Process of renal elimination b) Factors influencing passive reabsorption of drug from tubules 5. Interpret the bioavailability studies for approved drugs. 6. Write the factors of drug distribution and write briefly on volume of distribution. 7. Describe different properties of drugs that influence its distribution. 8. Discuss the role of protein binding on distribution and effect of drugs. 9. Construct the study design for bio equivalent studies. 10. Discuss the procedure and protocol (CDSCO) for testing of bioavailability of drugs. 11. Discuss the binding of drugs to various proteins by giving examples. 12. Write about the kinetics of protein binding.
  • 2. 13. Describe the concept of drug clearance by glomerular filtration and tubular secretion. 14. Write about the significance of drug excretion. 15. What is the role of glomerular filtration in drug excretion and write methods used to determine GFR? 16. Write about excretion of drug through i) bile ii) lungs 17. Define therapeutic equivalent, therapeutic substitution, Brand drug and generic drug. 18. Write oxidative-reductive pathway of drug metabolism. Write few examples in this section. 19. What is ANOVA? How it is determined? What are the parameters required? How significance and not significance can be determined. 20. What are the different t-tests applied and write its differences? Give the steps involved in unpaired t- test? 21. Write a note on: i) Histogram ii) Regression equations. 22. Enumerate different biostatistical methods and explain t-test and regression analysis. 23. Write short note on the following: a) Hydrolytic reactions b) Kinetics of protein binding c) In vitro-in vivo correlation 24. Write different in-vitro dissolution studies for solid dosage forms. Explain about pH- partition Hypothesis in detail. 25. Explain about the principal processes of drug excretion through the kidneys. Explain about effect of urine pH on drug excretion through kidneys. 26. Explain about curve fitting and regression analysis. Write about t- test. 27. Discuss that bioavailability testing procedure and protocol as per CDSCO. UNIT: III 1. Compare and contrast Pharmacokinetics and Pharmacodynamics. 2. Choose the formula to calculate Vd and define it. 3. Describe the theory of probability and its significance in pharmacokinetics 4. What is Km and Vmax. 5. Find a method for estimation of Vmax. 6. Discuss Biopharmaceutical Classification System by giving examples. 7. Classify compartment modeling. Merits and demerits? 8. Draw a typical plasma drug concentration curve and explain its salient features. 9. Explain about the methods of residuals used for the determination of absorption rate constant. 10. Write the determination of one compartment open IV bolus equation. Draw plasma concentration time curve and explain each parameter after oral administration of drug. 11. Write the significance of compartment modeling? Write the calculation of pharmacokinetic parameters from urinary data? 12. Write the determination of absorption rate constant by different methods.
  • 3. 13. Define one-compartment open model. Derive the equations to calculate plasma concentration of drug for I.V.Bolus. Define Biological half life of a drug and it’s importance. 14. Define the following: 15. i) Biopharmaceutics ii) Pharmacokinetics iii) Pharmacodynamics iv) Therapeutic index UNIT: IV No significant questions found and given previously from two compartment model UNIT: V 1. Illustrate the Methylation reaction for metabolism of drugs. 2. Explain Phase II metabolism by giving examples. 3. Discuss: a) Glucuronic acid conjugation b) Glutathione conjugation of drugs. 4. Compile enzyme induction and inhibitions. 5. Write the reasons for drugs exhibiting nonlinear pharmacokinetics. 6. Describe about oxidative biotransformation of drugs with examples. 7. Write overview on non linear pharmacokinetics. 8. Enumerate different Phase-II metabolic reactions and explain any two of them. Write about Enzyme induction. 9. Discuss in detail different oxidative reactions with suitable examples. 10. What is non-linear pharmacokinetics and discuss the reasons behind non-linearity and how it effects the clinical output of any drug?